Assistant professor Mei He, Ph.D., has joined the department of pharmaceutics from the University of Kansas. He received her doctoral degree from the University of Alberta and completed her postdoctoral training at the University of California, Berkeley. Her research focuses on precise definition and control of immunity at the molecular level to tissue level, via extracellular vesicles and exosomes-mediated delivery and biological programming strategies, which can be employed in advancing cancer immunotherapy, regenerative medicine and precision therapeutics.
He is an advisory board member of the journal Lab on a Chip, or LOC, and a reviewer board member of the journal Pharmaceutics. She received an NIH Maximizing Investigator’s Research Award for Early Stage Investigators in 2019. She has also received the LOC Emerging Investigator Award in 2019 and an LOC Outstanding Reviewer award in 2018 by the Royal Society of Chemistry.
Her publications have be recognized as one of the Most Downloaded Articles of 2016 (LOC), the Featured Cover Story of 2018 (LOC), Technology Reader’s Choice Award of 2018 (Society for Laboratory Automation and Screening) and one of the Top 100 Read Articles of 2019 (Scientific Reports from Nature Publishing Group). He holds nine patents, and she is the founder of startup company Clara Biotech, Inc., which brings innovative solutions to the forefront of precision therapeutic applications.